Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Samsung Bio eyes construction of sixth manufacturing plant to kickstart 2025
4 months ago
Manufacturing
Eli Lilly misses 2024 revenue expectations, stock dips 7%
4 months ago
Pharma
Manufacturing
HHS inspector general raises concerns over three FDA accelerated approvals
4 months ago
FDA+
Lykos upheaval continues with four new board exits amid hunt for cash
4 months ago
People
Financing
Charles River disappoints investors with damp outlook for 2025
4 months ago
Manufacturing
Umoja’s $100M Series C will advance its bid for more convenient cell therapies
4 months ago
Financing
Cell/Gene Tx
Regenxbio sells Hunter syndrome license with FDA filing underway
4 months ago
Deals
Australia's BioCina and NovaCina join forces to make one CDMO
4 months ago
Deals
Manufacturing
Regeneron, Illumina invest in Truveta; Inhibrx Bio’s $150M loan
4 months ago
News Briefing
FTC goes after pharma middlemen's price hikes on 'specialty' drugs
4 months ago
Pharma
Law
Can the Pfizer machine fight back against an activist investor?
4 months ago
Pharma
Anavex reports long-term Alzheimer's data for drug with history of scrutiny
4 months ago
R&D
The healthcare companies sitting out this year's JP Morgan Healthcare Conference
4 months ago
Health Tech
Exclusive: Day after GSK buyout, IDRx chair takes new investing role at Curie.Bio
4 months ago
People
Startups
Daiichi Sankyo brings Glycotope antibody in-house for $132.5M
4 months ago
Deals
R&D
#JPM25 live blog day 2: Nvidia makes it fun; The year's 10th megaround
4 months ago
Pharma
Biohaven’s protein degrader is promising in early IgAN trial, heads straight to Phase 3
4 months ago
R&D
Health tech funding in 2025 kicks off with megarounds
4 months ago
Financing
Health Tech
How a startup is reimagining health insurance, as employers search for new options
4 months ago
Health Tech
BIO CEO plans to join FDA modernization advisory board under Trump administration
4 months ago
FDA+
Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaks
4 months ago
People
Pharma
Moderna lowers 2025 revenue estimate, announces more cost cuts
4 months ago
Pharma
Coronavirus
Federal Circuit upholds Novartis patent for heart drug Entresto
4 months ago
Pharma
Law
AbbVie partners with Simcere Pharma unit to develop myeloma drug
4 months ago
R&D
Pharma
First page
Previous page
54
55
56
57
58
59
60
Next page
Last page